摘要 |
Provided are methods for treating a neurodegenerative disease, such as multiple sclerosis, in a subject who does not present with active lesions (e.g., gadolinium-enhancing lesions), comprising administering an estrogen receptor β ligand to the subject without conjointly administering a second immunotherapeutic agent. For example, any immunotherapeutic agent that the subject is receiving may be discontinued, e.g., upon determining that the brain of the subject does not present with active lesions. The method may include determining whether the brain of the subject presents with active lesions, e.g., by gadolinium-enhanced MRI. |